All lobbying filings
CAPITOL HILL CONSULTING GROUP
CAPITOL HILL CONSULTING GROUP filed a Q3 termination report for OCULAR THREPEUTIX on October 20, 2026, reporting $20,000 in lobbying income.
Lobbying for OCULAR THREPEUTIX · Biopharmaceutical company focused on therapies for the eye.
Amended
Filing · LD-2 quarterly report
Q3 termination
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Representation ended
Sep 30, 2026
The registrant reported terminating its work for this client.
Lobbyists on this filing
4
-
BRIAN SUTTERPreviously held: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
-
CHRISTOPHER DAVISPreviously held: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
-
EMILY ELIZABETH WILKINSON-HOLLANDPreviously held: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).
-
KIMBERLEE TRZECIAK New on this filingPreviously held: FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA
Government bodies contacted
4
Lobbying activity
1
Issues related to Medicare reimbursement for therapies of the eye.